332 related articles for article (PubMed ID: 21076037)
1. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.
Thanopoulou K; Fragkouli A; Stylianopoulou F; Georgopoulos S
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20816-21. PubMed ID: 21076037
[TBL] [Abstract][Full Text] [Related]
2. Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain.
Husemann J; Silverstein SC
Am J Pathol; 2001 Mar; 158(3):825-32. PubMed ID: 11238031
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
[TBL] [Abstract][Full Text] [Related]
4. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
[TBL] [Abstract][Full Text] [Related]
5. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
Katsouri L; Georgopoulos S
PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
[TBL] [Abstract][Full Text] [Related]
6. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
[TBL] [Abstract][Full Text] [Related]
7. Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid.
Alarcón R; Fuenzalida C; Santibáñez M; von Bernhardi R
J Biol Chem; 2005 Aug; 280(34):30406-15. PubMed ID: 15987691
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.
Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE
J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287
[TBL] [Abstract][Full Text] [Related]
9. ApoE facilitates the microglial response to amyloid plaque pathology.
Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
[TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
11. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.
Coraci IS; Husemann J; Berman JW; Hulette C; Dufour JH; Campanella GK; Luster AD; Silverstein SC; El-Khoury JB
Am J Pathol; 2002 Jan; 160(1):101-12. PubMed ID: 11786404
[TBL] [Abstract][Full Text] [Related]
12. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM
Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648
[TBL] [Abstract][Full Text] [Related]
13. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
[TBL] [Abstract][Full Text] [Related]
15. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
[TBL] [Abstract][Full Text] [Related]
16. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
[TBL] [Abstract][Full Text] [Related]
17. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors.
Huang F; Buttini M; Wyss-Coray T; McConlogue L; Kodama T; Pitas RE; Mucke L
Am J Pathol; 1999 Nov; 155(5):1741-7. PubMed ID: 10550330
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
19. Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.
Van Vickle GD; Esh CL; Daugs ID; Kokjohn TA; Kalback WM; Patton RL; Luehrs DC; Walker DG; Lue LF; Beach TG; Davis J; Van Nostrand WE; Castaño EM; Roher AE
Am J Pathol; 2008 Aug; 173(2):483-93. PubMed ID: 18599612
[TBL] [Abstract][Full Text] [Related]
20. Knockout of apolipoprotein A-I decreases parenchymal and vascular β-amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
Contu L; Carare RO; Hawkes CA
Neuropathol Appl Neurobiol; 2019 Dec; 45(7):698-714. PubMed ID: 31002190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
